Halozyme Therapeutics reported $6.1B in Market Capitalization this May of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 1.78B 0.94B
Aptinyx Inc APTX:US $ 0.15B 0.03B
Cytokinetics CYTK:US $ 3.15B 0.68B
Dbv Technologies DBVT:US 0.19B 0.36B
Immunogen IMGN:US $ 1.05B 0.54B
Intrexon XON:US $ 1.03B 0.32B
IONIS PHARMACEUT IONS:US $ 4.3B 0.44B
Minerva Neurosciences NERV:US $ 0.04B 0B
Nektar Therapeutics NKTR:US $ 2.49B 0.81B
Peregrine Pharmaceuticals PPHM:US $ 1.32B 0.24B